. As a consequence of extensive work carried out over the past 15 years, we now know that the TLRs specifically recognize and respond to microbial molecules. Such molecules include lipopolysaccharide and flagellin, which decorate Gram-negative bacteria, and lipopeptides, which are essential constituents of the Gram-positive bacterial cell wall 3 . However, as increasing numbers of PRR ligands were identified, it became evident that these ligands are not unique to pathogenic bacteria, but are also found in the non-pathogenic and commensal bacterial strains that make up our microbiota and with which we have a beneficial and often mutualistic relationship 4 . Thus, it became apparent that the term 'PAMP' was a misnomer, and these ligands are now described more appropriately as microorganism-associated molecular patterns (MAMPs).
The realization that the ligands recognized by PRRs are in fact often shared by pathogens and commensals prompted some investigators in the field of host pathogenesis to revisit the question of how the host responds to pathogenic microorganisms. In particular, it has raised the question of how the host augments the immune response specifically to pathogens while remaining tolerant to beneficial commensal bacteria 5, 6 . Several interesting hypotheses have been proposed. One idea that emerged in the 1990s was the danger theory, which was proposed by Matzinger as a parallel system to the PAMP-PRR model of microbial recognition. Matzinger suggested that the immune system does not recognize pathogens per se, but rather recognizes the damage that they cause 7 . In this model, no distinction is made as to how the damage occurs, and the model implies that it could be elicited either by sterile injury or by infectious agents. Matzinger later proposed that there are specific damageassociated molecular patterns (DAMPs) and that these molecules provide contextual cues to the immune system that there is a threat to the host 8, 9 . The danger theory is now well accepted in the context of sterile inflammation, and several self-derived immune elicitors have been identified, such as uric acid and high-mobility group protein B1 (HMGB1), both of which are released by damaged cells 10, 11 . However, whether DAMPs contribute to immune activation during infection is less clear and, moreover, it is not known whether these DAMP-triggered immune responses are beneficial to the host or only serve to cause immune pathology.
Another possible mechanism of discrimination between pathogens and nonpathogens, proposed by Vance, Isberg and Portnoy, depends on the location of recognition 12 . At a subcellular level, this 'patternsof-pathogenesis' hypothesis was suggested by the observation that the strongest immune responses are induced by cytoinvasive pathogens (such as Listeria spp.) that breach the immunological sanctity of the cytosol, which is normally devoid of bacterial products 13 . In a somewhat analogous manner, immune responses can also vary if bacteria are recognized in different tissue compartments. As an example, the immune response elicited by bacteria that are in the lumen of the gut -and hence interacting with the apical surface of the epithelial monolayer -is less vigorous than if the epithelial monolayer is breached and the basal membrane exposed to bacterial products 14 . In this case, discrimination is achieved through the sequestration of TLRs from the apical membrane into endosomes or to the basal aspect of the cell 14 , such that these TLRs can interact only with pathogenic invasive microorganisms that traverse the epithelial monolayer.
A third model to explain how a host distinguishes pathogens from commensals is based on the monitoring of bacterial viability by the host. An increase in bacterial viability is a cue that a potential infection is not being controlled and that the immune response needs to be amplified 15 . These and other ideas describing how the immune response is regulated in proportion to the 12, 16, 17 and are not explored further here. Instead, we focus on one particular model that enables the host to distinguish pathogens from non-pathogens, which has been termed effector-triggered immunity (ETI) (FIG. 1) . This mechanism of immune activation is probably of particular relevance in nonprofessional immune cells, such as epithelial cells, which are regularly in contact with a wide variety of microorganisms but which do not express the full repertoire of PRRs. Although the remainder of this article discusses only ETI, it is important to note that it is likely that several, if not all, of these models and pathways cooperate with conventional PRRs to ultimately define the level of response to a pathogenic microorganism. How these pathways might be integrated to affect the host immune response is as yet unknown.
For simplicity, we focus here broadly on the idea of discriminating 'pathogens' from 'non-pathogens' . We acknowledge that microorganisms should be considered as a spectrum that includes commensals, opportunists, mutualists and pathogens depending on their state and the state of the host. However, owing to space constraints, we do not discuss the potential role of microbial effectors in this range of host-microorganism interactions.
The origins of effector-triggered immunity
The long-standing idea of ETI grew out of the work of the plant immunologist Flor, who originally described an idea he termed 'gene-for-gene resistance' in the 1940s 18 . This hypothesis was based on the simple observation that some plants are susceptible and others are resistant to an identical microbial infection 18 . Based on this observation, Flor proposed a one-to-one relationship between a pathogen avirulence gene (Avr gene) and a plant resistance gene (R gene). According to this theory, resistant plants have in their genome an R gene that is required for the recognition of a specific Avr gene product encoded by the pathogen. Recognition of the Avr gene product by the R gene product was hypothesized to be sufficient to trigger a signalling cascade that leads to plant immunity and a resistant phenotype 19 . This provocative theory intrigued the field of modern plant immunity for more than 50 years. The discovery of the first Avr genes and the corresponding R genes in the 1980s validated Flor's hypothesis 20 . Various theories were proposed in an attempt to explain the molecular details, but, after it became apparent that many Avr genes encode bacterial effectors, plant immunologists settled on the term ETI to broadly describe all of the possible mechanisms 21, 22 . ETI is defined as a protective immune response that is triggered by the detection of microbial effectors. Various direct and indirect mechanisms of effector recognition have been suggested
. One specific mechanism of indirect recognition was an early proposition by Dangl and Jones termed the guard hypothesis 23 . In this model, the products of R genes monitor or 'guard' those crucial cellular processes that are often targeted and modified by the effectors secreted by pathogens. Although the guard hypothesis has gained the most widespread recognition, it is somewhat restrictive in its purest application, and hence we use the more encompassing term of ETI to describe direct and indirect recognition of microbial effectors.
Although it has been speculated for many years that ETI might have a role in animals 24, 25 , as well as in plants, several recent papers [26] [27] [28] [29] [30] have provided some of the first mechanistic descriptions of this phenomenon in animal hosts. This has prompted us to review the evidence suggesting the existence of alternative mechanisms of immune activation that are distinct from PRR-mediated signalling and to consider how ETI might apply to pathogen recognition in metazoans. Similar to the plant system, the model of ETI in animals suggests that the 'pathogenic potential' of a microorganism can be sensed because pathogenic bacteria express toxins that are absent from commensal and non-pathogenic bacteria. Unlike in plants, there is currently no evidence that animals directly recognize these pathogen effectors. It is possible that this is a consequence of the 'artificial' systems that have been studied in animals, which do not generally involve co-evolved hosts and microorganisms. However, our preferred hypothesis is that mechanisms of effector recognition will be revealed through the identification and study of resistant (rather than susceptible) hosts, as these are the most likely to express this type of recognition system. All of the known examples indicate that bacterial effectors are recognized indirectly in animal hosts because of the consequences of their activity on cellular homeostasis or the alterations they cause in their specific cellular targets (described in more detail below).
Bacterial effectors and the immune system
Pathogenicity can be considered as the ability of a microorganism to multiply and do damage to its host 31, 32 . To facilitate replication, pathogens secrete toxins and bacterial effectors, many of which enter the host cytosol through an array of bacterial secretion systems or by translocating across the plasma membrane 33 . Although the term 'effector' has been used to specifically describe bacterial proteins that are introduced directly into the host cell by a type III secretion system, for the purposes of this article we use the term 'effector' more loosely to describe any bacterial protein with intracellular targets, regardless of its mechanism of delivery. Once pathogen effectors gain access to the cytoplasm, they interact with host proteins and, in many cases, efficiently inhibit various aspects of the immune response, including phagocytosis, cell motility and the activation of immune signalling pathways 34, 35 . These effectors are often required for the microorganism to establish itself within its host and hence are often collectively referred to as 'virulence' factors. So far, large numbers of bacterial effectors have been identified that have an immune-inhibitory activity 36 , probably because this has been a focus of the field. Although the idea that effectors primarily mediate immune evasion is logically appealing, studies in plants and recent work in animals have shown that some pathogen effectors can elicit an immune response (TABLE 1) and that this can be protective for the host. Although perhaps counterintuitive if considered solely from an immune perspective, as discussed below these responses can be understood when considered in the context of co-evolved host-pathogen dynamics, for example if the host immune response is required for pathogen transmission. In plants, the molecular details of how ETI occurs are beginning to emerge, and it is clear that pathogen effectors can be recognized either directly or indirectly through their action on host components
. In addition, although they are not the focus of this article, there are examples of secreted toxins that function extracellularly and can also induce a defence reaction 37 .
Although ETI has a significant role in determining the outcome of the hostpathogen interaction in plants, the discovery of Arabidopsis thaliana FLAGELLIN-SENSITIVE 2 (FLS2) as a PRR that recognizes bacterial flagellin as a MAMP indicated that, similarly to animals, plants also use PRR-mediated sensing 38 . Indeed, FLS2 has marked similarities to TLR5, which detects bacterial flagellin in mammals. To conform with the ETI terminology, plant
Box 1 | Potential host strategies for sensing pathogen effectors

Susceptible strains
During the infection of a susceptible host that lacks resistance to a particular pathogen, the activity of bacterial effectors on their target proteins goes unchecked (see the figure) . This renders the host susceptible to infection with that specific pathogen.
Resistant strains
In a resistant host, pathogen effectors can be sensed directly or indirectly by resistance (R) proteins, and this results in a protective immune response.
Receptor-ligand model. Direct recognition occurs when a pathogen effector is directly recognized by a host receptor. Evidence of direct recognition of pathogen effectors in animals is currently lacking.
Guard hypothesis. In the guard model, certain important cellular targets are 'guarded' by a specific R protein, and an immune response is induced if they are perturbed. In model 1, engagement of the host target by the pathogen effector results in the modification of the target. This modification is recognized by the R protein to signal an immune response. In an alternative model (model 2), the R protein guard and the host target 'guardee' exist together in the healthy state and the immune response is repressed. During infection, the modification of the host target protein (guardee) by the pathogen effector liberates the R protein (guard), allowing the R protein to engage signalling pathways and induce a defence response.
Decoy model. The decoy model suggests that during evolution the host has acquired proteins that are decoys for the targets of pathogen effectors and that function as sentinels for the presence of these effectors. These decoys could arise through gene duplication events or could be splice variants of the normal target. However, decoys are generally thought to have no other primary function in the cell.
Bait-and-switch model. In this case, the pathogen effector is not sensed after binding its true target but rather is 'baited' by a decoy protein that engages an R protein. The function of the R protein switches to induce signalling once the pathogen effector is bound. 21, 22, 39 . Developing further on these observations, recent efforts have built an integrated framework of plant immunity that incorporates both ETI and PTI and have generated models that describe the cooperation between these two arms of the plant immune response. One particular model, the 'zig-zag' model, integrates the quantitative output of the two arms of the plant immune system for optimal defence and illuminates the molecular dialogue and co-evolution between ETI and PTI that occurs in plants during pathogen-host interactions 22 .
Immune activating effectors in animals
The identification of PTI as well as ETI in plants raised the possibility that there are more similarities between how plants and animals orchestrate microbial detection than were previously appreciated 38, 40, 41 . Extrapolating from this, it seemed plausible that ETI also occurs in metazoans but might have been overlooked because the field was highly focused on PRRs as the primary mechanism of immune surveillance. Several recent studies have provided mechanistic descriptions of ETI in animals.
Modification of signalling molecules. We recently showed that the Escherichia coli effector CNF1 (cytotoxic necrotizing factor 1) elicits a vigorous ETI response in Drosophila melanogaster 26 . As in the case of the other effectors described here, the host does not directly detect the presence of CNF1; rather, CNF1 is sensed after it modifies a host protein, the RHO-family GTPase Rac2. CNF1 causes the deamidation of glutamine 61 of D. melanogaster Rac2, converting that residue to glutamic acid and locking the protein in an active GTP-bound state. The active form of Rac2 triggers membrane ruffling to facilitate bacterial entry across the epithelial barrier. However, this modified form of Rac2 also interacts with the proximal immune adaptor protein IMD to induce activation of the IMD innate immune signalling pathway. Notably, flies lacking the PRRs that recognize E. coli (namely, peptidoglycan recognition protein-LC (PGRP-LC) and PGRP-LE) still responded to intoxication with CNF1, indicating that CNF1 is sufficient to induce a defence response in the absence of PRR ligation. Importantly, this response to CNF1 was protective and could confer resistance to bacterial challenge. Observations in mammalian epithelial cells have confirmed that a similar CNF1-mediated ETI response occurs after the modification of human RAC2 and its interaction with the IMD homologues receptor-interacting protein 1 (RIP1; also known as RIPK1) and RIP2 (also known as RIPK2 and RICK), which drive nuclear factor-κB (NF-κB) activation (FIG. 2) . Taken together, these data provide not only an example of ETI in metazoans but also a credible molecular mechanism for how it might occur. They thus helped to confirm ETI as a sensing system that is not limited to plants but also found in animals.
Translation inhibition. Additional studies support the existence of ETI in animals. Several examples have emerged from studies of pathogen effectors that disrupt protein translation [27] [28] [29] [30] . Translation is an essential cellular process that is of particular importance during microbial infection, when chemokines, cytokines and anti microbial peptides need to be produced rapidly and at high levels by host cells. Many bacteria and viruses have evolved strategies to disrupt host translation -for example, a quintet of effectors from Legionella pneumophila (namely, Lgt1, Lgt2, Lgt3, SidI and SidL) have been shown to have this activity 27 . Interestingly, these effectors were recently shown to be sufficient to induce the activation of mitogen-activated protein kinases (MAPKs) and to augment ongoing NF-κB signalling 28 (FIG. 2) . In the latter case, this effect was attributed to the blockade of the trans lation of NF-κB inhibitor (IκB). As IκB is a negative regulator of the TLR pathway, its loss is predicted to result in prolonged and increased NF-κB signalling and hence cytokine production downstream of TLR ligation (FIG. 2) . These data are in keeping with earlier observations showing that the response to L. pneumophila is highly dependent on the Legionella spp. Dot/Icm secretion system, which delivers bacterial effectors into host cells 42, 43 . Intriguingly, although the molecular details of how this occurs were not exhaustively explored, it was shown that the host response was triggered independently of the patternrecognition pathways mediated by TLRs and nucleotide-binding oligomerization domain protein 2 (NOD2), which is consistent with it being an ETI response 42 . Recent studies in Caenorhabditis elegans have revealed the contribution of ETI induced by translation inhibition during in vivo infection using a different system 29, 30 . These studies used Pseudomonas aeruginosa, which can be a highly virulent pathogen in many species, including C. elegans. It has been known for several years that C. elegans mounts a robust transcriptional response when infected by P. aeruginosa, as a consequence of the activation of several pathways, including the worm equivalent of the p38 MAPK pathway (that is, the PMK-1 pathway). However, investigators had failed to identify a bona fide MAMP-PRR recognition system in C. elegans that responds to P. aeruginosa. Two recent papers showed that a major component of the response to P. aeruginosa is triggered not by the interaction of a PRR with a MAMP, but rather in response to a P. aeruginosa exotoxin, ToxA 29, 30 . ToxA blocks the elongation of polypeptide chains through the ribosylation of elongation factor 2 (EF-2) and functions to prevent the translation of the crucial host defence molecules that are induced rapidly by the innate immune response. Importantly, ToxA is not recognized per se. Instead, the activity of ToxA in inhibiting protein synthesis by blocking the function of EF-2 is sensed. This translational inhibition in C. elegans paradoxically induces the translation of ZIP-2, which then induces an immune transcriptional response. Interestingly, the immune response elicited by ToxA also protected the worms from ToxA-mediated toxicity.
Pore-forming toxins. Several other bacterial effectors might be considered in this framework as elicitors of ETI (TABLE 1) , a particularly interesting group of which is the pore-forming toxins. These are a diverse group of proteins with divergent structures, peptide sequences and target cells that have a common function of generating pores in the plasma or endosomal membrane. When present in high concentrations, pore-forming toxins cause severe membrane disruption, the leakage of intracellular contents and rapid cellular death owing to lysis. However, at lower concentrations, the host cells can respond to the damage generated by pore-forming toxins and activate ETI responses in both C. elegans and mammals [44] [45] [46] [47] . Although the precise molecular mechanisms remain unclear, it seems that the efflux of K + ions and the influx of Ca 2+ ions caused by pore-forming toxins have a major role in this immune activation (FIG. 2) . In mammals, this results in two types of response: an antimicrobial response and a repair response. These two complementary outcomes are mediated by the activation both of MAPKs and stress-response pathways [47] [48] [49] [50] and of the NOD-, LRR-and pyrin domain-containing 3 (NLRP3) inflammasome. NLRP3 inflammasome activity results in the secretion of interleukin-1β (IL-1β) and IL-18 (REFS 45, 46) and regulates sterol regulatory element-binding proteins (SREBPs) that orchestrate membrane repair 46 . Repair can also be achieved through other pathways, such as the endocytosis and/or exocytosis of the damaged membrane and the embedded toxins 51, 52 . An interesting point raised by these studies of pore-forming toxins is that the response to microbial effectors is not nonspecific, but rather can activate pathways that are appropriate for counteracting the initiating insult (FIG. 2) . As an example, pore formation induces a membrane repair response that is likely to be important for facilitating tolerance to the bacterial burden and maintaining the fitness of the host 53 . By contrast, the response to other microbial toxins induces NF-κB signalling pathways and cytokine secretion, which recruits neutrophils and activates cellular defences.
Together, these examples of responses mediated by phylogenetically distant hosts (C. elegans, D. melanogaster and mammals) to disparate bacterial species (E. coli, L. pneumophila and P. aeruginosa) confirm that ETI is not restricted to plants but is actually an evolutionarily conserved strategy used by all species to sense and respond to pathogens.
Highly evolved pathogens manipulate ETI Whereas many bacteria prefer to evade the host immune response and to effectively colonize by stealth, other bacteria take the opposite approach and use the inflammatory response for their benefit. As an example, Salmonella and Shigella spp. deliberately activate immune signalling and inflammation in the gut as a means of disrupting the epithelial barrier to help them to become established in a particular niche 24 . Furthermore, this severe intestinal inflammation leads to diarrhoea, which has a pivotal role in the dissemination of the bacteria between hosts. Although it is unclear exactly how these enteropathogens trigger such florid inflammation in the gut, work in Salmonella spp. provides some evidence that it might be due, at least in part, to the entry of pro-inflammatory effectors into host cells in the gut. Supporting this Figure 2 | The outputs of effector-triggered immune responses are specific to the type of initiating damage. Different types of effector-triggered immunity (ETI) are associated with different outputs that can specifically counteract the original insult. After translocation into the cytoplasm, Escherichia coli-derived CNF1 (cytotoxic necrotizing factor 1) mediates RAC2 deamidation, which disrupts the intrinsic GTPase activity of RAC2 and locks it in an active GTP-bound state. RAC2 then interacts with receptor-interacting protein 1 (RIP1) or RIP2 to induce immune signalling and nuclear factor-κB (NF-κB) activation that results in a robust antibacterial response. Translation inhibition caused by Legionella pneumophila effectors induces a stress response through mitogen-activated protein kinase (MAPK) and associated pathways and amplifies NF-κB activation by causing the loss of NF-κB inhibitor (IκB). Bacterial pore-forming toxins cause potassium efflux and thereby decrease intracellular potassium concentrations. The low level of potassium is sensed through an unknown mechanism and induces a stress response (through a p38 MAPK signalling pathway in mammals and JUN N-terminal kinase (JNK) MAPK signalling in Caenorhabditis elegans) and the activation of the NOD-, LRR-and pyrin domain-containing 3 (NLRP3) inflammasome. Inflammasome activation is associated with both an antibacterial interleukin-1β (IL-1β) response and cell-autonomous membrane repair through a sterol regulatory element-binding protein (SREBP). The figure focuses primarily on the mechanisms that have been shown in mammals and does not represent the complete set of pathways that have been demonstrated in all species. As an example, ETI in response to translation inhibition in worms is mediated by ZIP-2 and is not shown. proposition, at least two studies have suggested that Salmonella enterica subsp. enterica serovar Typhimurium effectors can induce ETI responses in vivo. This was first speculated to explain observations made in vivo in a D. melanogaster model system, in which it was noted that mutant bacteria that lacked the type III secretion system unexpectedly grew to higher concentrations and were less effectively cleared from the fly 25 . The ability of Salmonella spp. effectors to induce immune responses was then confirmed in mammals 24 , and the molecular mechanism of this ETI explored. A trio of S. Typhimurium effectors that are delivered into host cells by the type III secretion system -SopE, SopE2 and SopB -has been shown to induce ETI responses in mammalian cells. SopE and SopE2 are guanine nucleotide exchange factors that seem to be partially redundant, and SopB functions as a phosphoinositide phosphatase that activates RHO-family GTPases and induces NF-κB signalling. The immune activation induced by SopE, SopE2 and SopB seems to be largely dependent on the RHO GTPase CDC42. However, CDC42 depletion does not completely abrogate immune activation, raising the possibility that additional GTPases are also involved 24 . As confirmation of the important contribution of ETI to the antibacterial response, the infection of cultured epithelial cells with triple-mutant S. Typhimurium lacking these three effectors elicits a similar host transcriptional response to that elicited by bacteria that lack the entire type III secretion system. This suggests that SopE, SopE2 and SopB are the main S. Typhimurium effectors responsible for the induction of ETI in the epithelium. A similar pro-inflammatory function has been attributed to the Yersinia pseudotuberculosis effector YopJ, which inhibits MAPK kinases (MAPKKs) and MAPKK kinases (MAPKKKs) and simultaneously activates caspase 1 . Caspase 1 activation in this context disrupts the intestinal barrier and has been suggested to promote infection and bacterial dissemination. Together, these recent examples suggest that highly evolved pathogens have learnt to use ETI to their advantage. As the inflammatory response in these cases favours the pathogen and not the host, we suggest that it might be better termed effector-triggered immune pathology (ETIP). Indeed, ETIP that occurs in the late stages of infection might be integral to the dissemination of the pathogen within a host population (FIG. 3) .
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Emerging themes in ETI
In most cases, the mechanisms responsible for ETI in metazoans remain incompletely understood and, with the exception of CNF1, the molecular details remain speculative. For this reason, it is hard to generalize beyond the identification of features of ETI that are common between animals and plants
. As an example, for the majority of pathogen effectors, eliminating their enzymatic activity disrupts their ability to induce an immune response. This observation suggests that the recognition of the effector is indirect and that an immune response is triggered by sensing the consequence of the effector rather than by direct recognition of the effector per se. Despite often targeting similar host pathways and having similar functional outcomes, bacterial effectors are often structurally very different. For this reason, a system of direct recognition would necessitate the evolution of a huge array of receptors able to accommodate such a structurally diverse set of ligands. Instead, through indirect recognition, the host can monitor perturbations in a few key cellular processes or proteins and, irrespective of how these modifications occur, mount an immune response. Thus, the repertoire of host sensing mechanisms required for the indirect recognition of bacterial effectors could be quite parsimonious while remaining responsive to a large spectrum of pathogens. Indeed, to minimize the 'cost' to the host, the recognition machinery of ETI is probably limited to monitor only Figure 3 | The co-evolution of pathogenic bacteria with the host immune response. In the absence of an immune response, bacteria quickly overwhelm their host. To contain these infections, the host has evolved pattern-triggered immunity, which is mediated through pattern-recognition receptors such as Tolllike receptors (TLRs). To deal with the threat from the host, bacteria can evolve inhibitory effector proteins, which disrupt host immune defences. This effectortriggered susceptibility promotes infection. In the next step of co-evolution, the host evolves the ability to detect the presence of bacterial effector proteins and induce effector-triggered immunity. In a final evolutionary step, hypervirulent bacteria (such as Shigella spp. and Salmonella enterica subsp. enterica serovar Typhimurium) have acquired the ability to deliberately activate immune signalling using activating effector proteins. The induced inflammatory response is associated with effector-triggered immune pathology, which promotes the colonization of the bacteria and aids their dissemination.
those cellular processes that are considered essential. Thus, the potential for not only direct but also indirect recognition of pathogens is one of the most versatile features of ETI as a proposed mechanism of immune surveillance.
Conclusion and perspective
Prompted by compelling studies that demonstrated the important role of ETI in plants, we and others have investigated whether this phenomenon also occurs in metazoans. We recently showed that an E. coli effector can elicit a vigorous response in an animal host (namely, D. melanogaster). This work, together with studies of Salmonella 24, 25 , Legionella 27, 28 and Pseudomonas 29, 30 spp., helped to confirm an integral role for ETI in modifying how animals respond to various potentially pathogenic microorganisms. This growing body of evidence has led us to revise our thinking about mechanisms of pathogen recognition in animals to accommodate ETI as an important system of immune surveillance that functions in a synergistic and/or parallel manner with PTI. This provides a fresh perspective on the recognition of pathogenic bacteria, and our future challenge will be to understand the molecular details of how ETI is induced by different effectors as well as its relative importance in the host response to different pathogens. Once equipped with that information, it is possible that therapeutic strategies could be developed to induce beneficial ETI responses. Such strategies could include the stimulation of mucosal defences or the use of mucosal adjuvants. Conversely, understanding how highly evolved pathogens such as Salmonella and Shigella spp. use ETI to their advantage will provide new insights into pathogenesis and help to identify anti-infectives that target this particular virulence strategy.
Glossary
Avirulence gene Damage-associated molecular patterns (DAMPs). Self-derived immune elicitors that indicate damage to the host. As a result of cellular stress, cellular damage or non-physiological cell death, DAMPs are released from various compartments, including the degraded stroma (in the case of hyaluronate, for example), the nucleus (in the case of high-mobility group protein B1) and the cytosol (in the case of ATP, uric acid, S100 calcium-binding proteins and heat-shock proteins). Such DAMPs are thought to elicit local inflammatory reactions.
Effector-triggered immune pathology (ETIP). An over-exuberant immune response induced by bacterial effectors that benefits the pathogen and is to the detriment of the host.
Effector-triggered immunity
(ETI). The detection of and response to microbial effectors that enter the host cell and trigger a protective immune response by the host.
Effector-triggered susceptibility (ETS). Immune suppression or evasion caused by bacterial effectors that enter the host cell and disrupt defence pathways.
IMD innate immune signalling pathway
One of two innate immune NF-κB signalling pathways in Drosophila melanogaster. The IMD pathway responds to DAP-type peptidoglycan from Gram-negative, and some Gram-positive, bacteria. This leads to the rapid and robust production of antimicrobial peptides.
Microorganism-associated molecular patterns (MAMPs) . After the realization that PAMPs are found in both pathogens and non-pathogens, the term MAMPs was suggested as a more appropriate description of the microbial ligands that bind to PRRs.
Pathogen-associated molecular patterns (PAMPs). The term originally used to describe the immune elicitors found in bacteria, but not in mammalian cells, that bind to PRRs and drive immune responses. Examples include terminally mannosylated and polymannosylated compounds, which bind to the mannose receptor, and various microbial products, such as bacterial lipopolysaccharides, hypomethylated DNA, flagellin and double-stranded RNA, which bind to Toll-like receptors. This term has now been superseded by MAMPs.
Pattern-recognition receptors
(PRRs). Proteins expressed by innate immune cells that detect molecules associated with microbial pathogens or cellular stress.
Pattern-triggered immunity
(PTI). The immune response elicited after the ligation of a PRR by its microbial ligand. A more appropriate term would in fact be MAMP-triggered immunity, for the reasons described above.
Resistance gene (R gene). The original plant terminology for a host gene encoding a protein that is required for the direct or indirect sensing of a pathogen effector and that elicits a protective immune response.
Sterile inflammation
Inflammation triggered by the danger signals that are induced by chemical or physical stress, in the absence of infection.
Type III secretion system
A specialized molecular machine present in some bacteria that allows the injection of bacterial proteins into host cells.
'Zig-zag' model
A model that was proposed to illustrate the quantitative output of the plant immune system and to explain the co-evolution of plant resistance genes and pathogen effectors.
